Oramed Pharmaceuticals sell IfYouCanDreamItYouCanDoIt
Start price
04.11.21
/
90%
€23.30
Target price
04.11.23
€10.00
Performance (%)
-42.83%
End price
16.12.21
€13.32
Summary
This prediction ended on 16.12.21 with a price of €13.32. IfYouCanDreamItYouCanDoIt correctly predicted massive losses of -42.83% for Oramed Pharmaceuticals. IfYouCanDreamItYouCanDoIt has 90% into this predictionOramed is a pharmaceutical company that focuses on the development of innovative oral delivery solutions for drugs that are traditionally administered through injection. The company is primarily dedicated to the development of an oral insulin capsule that can potentially revolutionize the treatment of diabetes. Their flagship product, ORMD-0801, is currently in Phase III clinical trials in the United States and has received Fast Track designation from the FDA. Oramed is a publicly traded company listed on the Nasdaq under the ticker symbol ORMP.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oramed Pharmaceuticals | 1.039% | 1.039% | 3.584% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to IfYouCanDreamItYouCanDoIt what are the pros and cons of Oramed Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by IfYouCanDreamItYouCanDoIt for this prediction
In the thread Oramed Pharmaceuticals diskutieren
Sell mit Kursziel 10,0